Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Proteome Sciences partners with EU for developing alternatives to animal tests
Proteome Sciences is undertaking the proteomics part of the Sens-it-iv project and has been awarded a grant of E571,000 over the period to 2010. This is an important
Proteome Sciences is undertaking the proteomics part of the Sens-it-iv project and has been awarded a grant of E571,000 over the period to 2010. This is an important
Patients in the Phase II randomized, double-blind, placebo-controlled, multi-center study in ulcerative colitis (UC) will be administered MDX-1100 at 10 mg/kg or placebo every two weeks for a
Mr Wieland brings to Cytochroma nearly 40 years of experience in finance and financial management, at both public and private companies, and will be based in the company’s
The ChloraPrep product line is said to expand the company’s offerings that help providers lower infection rates. Cardinal Health plans to accelerate sales of ChloraPrep products to both
Preliminary data from the trial showed that Hematide administered once every four weeks was well tolerated and maintained mean hemoglobin levels between 11 and 12g/dL in patients with
Novadaq also announced that Roger Deck, current CFO, will move to a senior business management role within the company and will work closely with Mr Rick Mangat, Novadaq’s
Novalar is establishing a specialty direct sales force to launch OraVerse in late 2008. Novalar’s sales force will focus on general and pediatric dentists for use in patients
Most recently, Mr Pitz served as vice president, finance, CFO and treasurer with Sybron Dental Specialties, a manufacturer of high technology dental, orthodontic, dental implant and infection prevention
The chewable tablets help to whiten teeth and improve breath though the use of a unique combination of safe, naturally occurring bacteria that are released in the mouth
Besides Germany, clopidogrel could also obtain its marketing authorization in Luxembourg within the second quarter of 2008. Applications for approval in additional European countries are in preparation. Antiplatelet